Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong
· Delayed Price · Currency is HKD 6.15
-0.02 (-0.32%)
Mar 10, 2026, 1:35 PM HKT
Sino Biopharmaceutical Employees
Sino Biopharmaceutical had 23,056 employees as of June 30, 2025. The number of employees decreased by 1,323 or -5.43% since the number was reported on December 31, 2024.
Employees
23,056
Change
-1,323
Growth
-5.43%
Revenue / Employee
1.45M HKD
Profits / Employee
183.99K HKD
Market Cap
110.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 23,056 | -1,323 | -5.43% |
| Dec 31, 2024 | 24,379 | -1,427 | -5.53% |
| Dec 31, 2023 | 25,806 | -466 | -1.77% |
| Dec 31, 2022 | 26,272 | 693 | 2.71% |
| Dec 31, 2021 | 25,579 | 1,471 | 6.10% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Akeso | 3,529 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,870 |
| Innovent Biologics | 6,190 |
| WuXi Biologics | 12,552 |
| RemeGen | 3,070 |
| 3SBio | 6,268 |
| BeOne Medicines AG | 11,000 |
| Shanghai Henlius Biotech | 3,537 |
Sino Biopharmaceutical News
- 5 days ago - Sino Biopharmaceutical (SBHMY) Strikes $1.53B Deal with Sanofi for Cancer Drug - GuruFocus
- 5 days ago - China outlicensing tops US$52 billion in first 2 months on rise in global deals - South China Morning Post
- 6 days ago - Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters
- 2 years ago - Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln - Reuters
- 5 years ago - Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea - Forbes